Die Ausgrabungen in St. Ulrich und Afra in Augsburg 1961-1968 Joachim Werner A. Radnóti W. Haas W. Volkert A. France-Lanord W. Ruckdeschel G. Ziegelmayer H. U. Nuber B. Bischoff H. Fillitz M. Weidemann F. Prinz G. Pohl W. Czysz B. Overbeck P. R. Franke I. Fingerlin

Autor: Ulbert, Thilo

Publikováno v: Gnomon, 1980 Jan 01. 52(4), 372-376.

Externí odkaz: https://www.jstor.org/stable/27687536

Fibrinolysis is impaired in patients with primary immune thrombocytopenia.

Autor: Schramm T; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Rast J; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Mehic D; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Reitsma SE; Department of Pathology and Laboratory Medicine and University of North Carolina at Chapel Hill (UNC) Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., de Moreuil C; Internal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France; Unité Mixte de Recherche (UMR) 1304, Groupe d'Etude de Thrombose de Bretagne Occidentale (GETBO), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Brest, Brest, France., Fillitz M; Department of Internal Medicine, Hanusch Krankenhaus, Vienna, Austria., Quehenberger P; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., de Laat B; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Functional Coagulation, Synapse Research Institute, Maastricht, The Netherlands; Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, The Netherlands., Wolberg AS; Department of Pathology and Laboratory Medicine and University of North Carolina at Chapel Hill (UNC) Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ay C; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Pabinger I; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Gebhart J; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria. Electronic address: johanna.gebhart@meduniwien.ac.at.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Nov; Vol. 22 (11), pp. 3209-3220. Date of Electronic Publication: 2024 Aug 28.

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.

Autor: Ludwig H; Department of Medicine I, Clinic Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria., Melchardt T; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria., Sormann S; Department of Hematology, University Clinic for Internal Medicine, Graz, Austria., Schreder M; Department of Medicine I, Clinic Ottakring, Vienna, Austria., Andel J; Department of Internal Medicine II, Pyhrn-Eisenwurzen Klinikum Steyr, Steyr, Austria., Hartmann B; Department of Internal Medicine II, LKH Rankweil, Rankweil, Austria., Tinchon C; Department for Hematology, Oncology and Palliative Care, LKH Hochsteiermark, Standort Leoben, Standort Leoben, Austria., Zojer N; Department of Medicine I, Clinic Ottakring, Vienna, Austria., Gunsilius E; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria., Podar K; Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria.; Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria., Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria., Willenbacher W; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria.; syndena GmbH, Connect to Cure, Innsbruck, Austria., Wöll E; Department of Internal Medicine, St. Vinzenz Krankenhaus Zams, Zams, Austria., Ruckser R; Department of Medicine II, Clinic Donaustadt, Vienna, Austria., Bozic B; Department of Medicine II, Clinic Donaustadt, Vienna, Austria., Krauth MT; University Clinic for Internal Medicine I, AKH, Medical University of Vienna, Vienna, Austria., Petzer A; Department of Internal Medicine I, BHS Linz, Linz, Austria., Schmitt C; Clinic for Internal Medicine 3, Kepler University Clinic Linz, Linz, Austria., Machherndl-Spandl S; Department of Internal Medicine I, Elisabethinen, Linz, Austria., Agis H; Department of Internal Medicine I, Division of Oncology, Medical University Vienna, Vienna, Austria., Fillitz M; Department of Internal Medicine, Hanusch Krankenhaus, Vienna, Austria., Wang SY; Medical Clinic and Policlinic I, University Clinic Leipzig, Leipzig, Germany., Zabernigg A; Department of Internal Medicine, Kufstein County Hospital, Kufstein, Austria., Knop S; Klinik für Innere Medizin 5, Schwerpunkt Onkologie/Hämatologie, Klinikum Nürnberg Nord, Nürnberg, Germany., Paiva B; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), CCUN, IDISNA, Pamplona, Spain., Greil R; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria.

Publikováno v: American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 1008-1011. Date of Electronic Publication: 2024 Feb 29.

Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.

Autor: Gelbenegger G; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Jaeger U; Division of Haematology and Haemostasis, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Fillitz M; Department of Medicine, Hanusch Krankenhaus, Vienna, Austria., D'Sa S; University College London Hospitals (UCLH) Centre for Waldenströms Macroglobulinaemia and Related Conditions, UCLH, National Health Service (NHS) Foundation Trust, London, UK., Cartwright R; Worthing Hospital, Western Sussex Hospitals, NHS Foundation Trust, Worthing, UK., Shafer F; Sanofi, Cambridge, Massachusetts, USA., Wardecki M; Sanofi, Warsaw, Poland., Wang J; Sanofi, Cambridge, Massachusetts, USA., Schoergenhofer C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Publikováno v: British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (4), pp. e59-e62. Date of Electronic Publication: 2022 Jun 02.

Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Autor: Ivanov D; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Milosevic Feenstra JD; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Sadovnik I; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Herrmann H; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria., Peter B; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Willmann M; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Department for Companion Animals, Clinical Unit for Internal Medicine, University of Veterinary Medicine Vienna, Vienna, Austria., Greiner G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria., Slavnitsch K; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Institute of in vivo and in vitro Models, University of Veterinary Medicine Vienna, Vienna, Austria., Hadzijusufovic E; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Department for Companion Animals, Clinical Unit for Internal Medicine, University of Veterinary Medicine Vienna, Vienna, Austria., Rülicke T; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria., Dahlhoff M; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Institute of in vivo and in vitro Models, University of Veterinary Medicine Vienna, Vienna, Austria., Hoermann G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; MLL Munich Leukemia Laboratory, Munich, Germany., Machherndl-Spandl S; Hospital Ordensklinikum Elisabethinen Linz, Linz, Austria.; Johannes Kepler University, Medical Faculty, Linz, Austria., Eisenwort G; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Third Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria., Fillitz M; Third Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria., Sliwa T; Third Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria., Krauth MT; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Bettelheim P; Hospital Ordensklinikum Elisabethinen Linz, Linz, Austria., Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Koller E; Third Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria., Pfeilstöcker M; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Third Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria., Gisslinger H; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Keil F; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Third Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria., Kralovics R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.

Publikováno v: American journal of hematology [Am J Hematol] 2023 May; Vol. 98 (5), pp. 770-783. Date of Electronic Publication: 2023 Mar 09.